Lewis Earl 4
4 · TECOGEN INC. · Filed Jun 30, 2026
Research Summary
AI-generated summary of this filing
Tecogen Director Lewis Earl Receives Award for 25,000 Shares
What Happened
- Lewis Earl, a director of Tecogen Inc. (TGEN), was granted a derivative award for 25,000 shares on 2026-06-26. The reported price associated with the award is $5.17 per share, for a total reported value of $129,250. This transaction is an acquisition/award (not a sale).
Key Details
- Transaction date: 2026-06-26; Filing date: 2026-06-30 (filed timely).
- Transaction type: A (grant/award of a derivative security).
- Shares/units: 25,000; Price shown: $5.17; Total value reported: $129,250.
- Vesting: Vests 25% per year (footnote), implying a four-year vesting schedule.
- Shares owned after transaction: Not disclosed in the filing.
- No 10b5-1 plan, tax-withholding, or late-filing flags indicated in the filing.
Context
- This was a derivative equity award (commonly RSUs or similar units) that will convert to or permit acquisition of common shares according to the vesting schedule; it does not reflect an immediate open-market purchase or sale. Such awards are typically part of compensation and should be interpreted as an acquisition of equity-linked compensation rather than an immediate liquidity action.
Insider Transaction Report
Form 4
TECOGEN INC.TGEN
Lewis Earl
Director
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-06-26$5.17/sh+25,000$129,250→ 25,000 totalExercise: $5.17From: 2027-06-26Exp: 2036-06-26→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]Vests 25% per year
Signature
/s/ Earl R. Lewis|2026-06-30